文献速递角膜与眼表疾病青光眼眼整形与眼眶

美容性虹膜植入物的并发症及其处理

Complications and Management of Cosmetic Iris Implants.
PubMed 文献 · Am J Ophthalmol · 2025-06-04

英国伦敦Moorfields眼科医院2008年1月至2023年12月收治的15例(30眼)美容性虹膜植入物相关并发症患者,中位取出时间45.5个月,常见并发症包括葡萄膜炎(60%)、需青光眼手术的眼压升高(33.3%)、需角膜内皮移植的角膜失代偿(20%)和白内障形成需超声乳化(13.3%)。作者认为该植入物与严重威胁视力的并发症相关,建议全球禁止美容性虹膜植入。

要点

  • 美容性虹膜植入物可导致葡萄膜炎、青光眼、角膜失代偿等严重威胁视力的并发症。
  • 取出植入物后,相当比例患者仍存在持续症状并需二次手术。
  • 作者建议全球禁止美容性虹膜植入,并需加强监管。

核心结论

  • 美容性虹膜植入物与角膜失代偿、青光眼和葡萄膜炎等严重威胁视力的并发症相关。
  • 许多患者在取出植入物后仍需多次手术干预,凸显该装置的长期致病率。
  • 作者建议鉴于重大风险且缺乏治疗价值,应全球禁止美容性虹膜植入,并需加强监管以防进一步伤害。

研究设计与样本

  • 单中心回顾性干预性病例系列。
  • 纳入2008年1月至2023年12月英国伦敦Moorfields眼科医院收治的15例(30眼)美容性虹膜植入物相关并发症患者。
  • 植入时平均年龄34.13±9.51岁,以亚洲族裔(53%)和男性(60%)为主。
  • 回顾病历分析人口学、取出术前参数、并发症、处理及结局,采用配对t检验和Pearson相关系数进行统计分析。

主要发现

  • 中位取出时间为45.5个月(范围6.0-140.1个月)。
  • 最常见并发症包括葡萄膜炎(60%)、需青光眼手术的眼压升高(33.3%)、需角膜内皮移植(DMEK)的角膜失代偿(20%)和需超声乳化白内障手术的白内障形成(13.3%)。
  • 取出时间与角膜失代偿呈统计学显著正相关(r=0.392,P=.048)。
  • 行DMEK的患者(n=6)术后内皮细胞计数从778.33±191.53 cells/mm²显著增至1107.33±17.96 cells/mm²(P=.009),平均中央角膜厚度从783.17±293.93 µm降至508.83±48.94 µm(P=.1)。
  • 尽管进行了这些干预,相当比例患者仍存在持续症状需二次手术。

临床怎么用

  • 作者建议全球禁止美容性虹膜植入,并需加强监管以防进一步伤害。
  • 原文未据此给出其他临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the complications, management, and outcomes associated with cosmetic iris implants. DESIGN: Single-center retrospective interventional case series. SUBJECTS: 30 eyes of 15 patients who presented to Moorfields Eye Hospital, London, UK with complications related to cosmetic iris implants between January 2008 and December 2023. Mean age at implantation was 34.13 ± 9.51 years, with predominantly Asian ethnicity (53%) and male gender (60%). METHODS: Medical records were reviewed for patient demographics, pre-explantation parameters, complications, management, and outcomes. Best-corrected visual acuity (BCVA), intraocular pressure (IOP), endothelial cell count (ECC), and central corneal thickness (CCT) were analyzed before and after explantation. Secondary interventions were documented, and statistical analyses were performed using paired t-tests and Pearson correlation coefficients. MAIN OUTCOME MEASURES: BCVA, IOP, ECC, CCT, presence of uveitis, glaucoma, corneal decompensation, cataract formation, and need for secondary surgical interventions. RESULTS: Median time to explantation was 45.5 months (range: 6.0-140.1 months). The most common complications included uveitis (60%), elevated IOP requiring glaucoma surgery (33.3%), corneal decompensation requiring Descemet's Membrane Endothelial Keratoplasty (20%), and cataract formation requiring phacoemulsification (13.3%). A statistically significant positive correlation was found between time to explantation and corneal decompensation (r = 0.392, P = .048). In patients who underwent DMEK (n=6), ECC increased significantly from 778.33 ± 191.53 cells/mm² to 1107.33 ± 17.96 cells/mm² postoperatively (P = .009), and mean CCT decreased from 783.17 ± 293.93 µm to 508.83 ± 48.94 µm (P = .1). Despite these interventions, a considerable proportion of patients experienced persisting symptoms requiring secondary surgery. CONCLUSIONS: This case series demonstrates that cosmetic iris implants are associated with serious sight-threatening complications including corneal decompensation, glaucoma, and uveitis. Many patients required multiple surgical interventions after explantation, highlighting the long-term morbidity associated with these devices. The authors recommend that cosmetic iris implantation should be banned worldwide given the substantial risks and lack of therapeutic value, and greater regulatory oversight is needed to prevent further harm to patients.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Balal S, Jamall O, Janmohamed IK, et al. Complications and Management of Cosmetic Iris Implants. Am J Ophthalmol. 2025. PMID: 40480347. doi:10.1016/j.ajo.2025.05.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。